Published in HPB Surg on February 01, 2010
Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, the interventional oncology sans frontières meeting 2013. Eur Radiol (2015) 1.07
Liver resection for colorectal cancer metastases. Curr Oncol (2013) 0.89
Minimally invasive local therapies for liver cancer. Cancer Biol Med (2014) 0.88
Radiofrequency ablation versus resection for colorectal cancer liver metastases: a meta-analysis. PLoS One (2012) 0.83
Complementary use of resection and radiofrequency ablation for the treatment of colorectal liver metastases: an analysis of 395 patients. World J Surg (2013) 0.76
Radiofrequency Ablation versus Liver Resection for Colorectal Cancer Liver Metastasis: An Updated Systematic Review and Meta-analysis. Chin Med J (Engl) (2016) 0.75
Comparison of Hepatic Resection and Radiofrequency Ablation for the Treatment of Colorectal Liver Metastasis. Indian J Surg (2015) 0.75
Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg (2004) 55.13
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg (1999) 14.31
Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg (2004) 6.75
Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg (2002) 6.24
Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology (2001) 3.85
Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg (2005) 3.02
Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? Ann Surg Oncol (2007) 2.83
Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients. Radiology (1997) 2.47
Hepatic metastases: percutaneous radio-frequency ablation with cooled-tip electrodes. Radiology (1997) 2.27
Local recurrence after laparoscopic radiofrequency thermal ablation of hepatic tumors. Ann Surg Oncol (2000) 2.21
Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg (2003) 2.13
Solitary colorectal liver metastasis: resection determines outcome. Arch Surg (2006) 2.06
Learning curve for radiofrequency ablation of liver tumors: prospective analysis of initial 100 patients in a tertiary institution. Ann Surg (2004) 1.99
Radiofrequency ablation of malignant liver tumors. Oncologist (2001) 1.97
Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR Am J Roentgenol (2000) 1.95
Ultrasound-guided radiofrequency thermal ablation of liver tumors: percutaneous, laparoscopic, and open surgical approaches. J Gastrointest Surg (2002) 1.84
Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg (2006) 1.76
Local recurrences after intraoperative radiofrequency ablation of liver metastases: a comparative study with anatomic and wedge resections. Ann Surg Oncol (2004) 1.69
Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors. Arch Surg (2001) 1.54
Current value of intraoperative sonography during surgery for hepatic neoplasms. World J Surg (2002) 1.48
Radiofrequency ablation of liver tumors: influence of technique and tumor size. Surgery (2002) 1.47
Radiofrequency ablation in 447 complex unresectable liver tumors: lessons learned. Ann Surg Oncol (2003) 1.46
The value of intraoperative ultrasound during hepatic resection compared with improved preoperative magnetic resonance imaging. Eur J Ultrasound (2003) 1.43
Hepatic radiofrequency ablation. Arch Surg (2002) 1.42
A study of prognostic factors for hepatic resection for colorectal metastases. Am J Surg (1997) 1.41
Radiofrequency ablation of colorectal liver metastases. Abdom Imaging (2005) 1.30
Influence of operator experience in radiofrequency ablation of malignant liver tumours on treatment outcome. Eur J Surg Oncol (2006) 1.11
Local recurrence after laparoscopic radiofrequency ablation of liver tumors: an analysis of 1032 tumors. Ann Surg Oncol (2008) 1.09
Local, intrahepatic, and systemic recurrence patterns after radiofrequency ablation of hepatic malignancies. J Gastrointest Surg (2002) 1.07
Surgical treatment and other regional treatments for colorectal cancer liver metastases. Oncologist (1999) 1.06
Resection versus laparoscopic radiofrequency thermal ablation of solitary colorectal liver metastasis. J Gastrointest Surg (2008) 1.00
Cryosurgery and radiofrequency ablation for unresectable colorectal liver metastases. Eur J Surg Oncol (2005) 0.92
Liver resection for hepatic metastases: 15 years of experience. J Hepatobiliary Pancreat Surg (2002) 0.87
Canadian breast cancer guidelines: have they made a difference? CMAJ (2007) 1.25
Short- and long-term outcomes following percutaneous cholecystostomy for acute cholecystitis in high-risk patients. Surg Endosc (2011) 1.07
Decreased hepatocyte membrane potential differences and GABAA-beta3 expression in human hepatocellular carcinoma. Hepatology (2007) 0.97
GABA-B receptor activation inhibits the in vitro migration of malignant hepatocytes. Can J Physiol Pharmacol (2011) 0.84
Trends in time to diagnosis of colon cancer and impact on clinical outcomes. Can J Gastroenterol (2012) 0.81
Factors associated with physical activity among Canadian high school students. Int J Public Health (2011) 0.80
The new and improved two-sample T test. Psychol Sci (2004) 0.78
Physician attitudes and treatment patterns for pancreatic cancer. World J Surg Oncol (2011) 0.77
Adaptive robust estimation and testing. Br J Math Stat Psychol (2007) 0.76
Cancer stem cell invasion of the hepatic microvasculature as a predictor of tumour recurrence following surgical resection in adult patients with hepatocellular carcinoma. Can J Gastroenterol Hepatol (2015) 0.75
Blastomycosis presenting as multiple splenic abscesses: Case report and review of the literature. Can J Infect Dis Med Microbiol (2010) 0.75
A population-based analysis of the morbidity and mortality of gallbladder surgery in the elderly. Surg Endosc (2013) 0.75
A comparative study of robust tests for spread: asymmetric trimming strategies. Br J Math Stat Psychol (2008) 0.75
Predicting Hepatocellular Carcinoma Recurrence and Survival. Hepatogastroenterology (2014) 0.75
Comparing measures of the 'typical' score across treatment groups. Br J Math Stat Psychol (2004) 0.75
In vivo 1H MRS of human gallbladder bile at 3 T in one and two dimensions: detection and quantification of major biliary lipids. NMR Biomed (2014) 0.75